ATLAS / Macro Radar / Reporting / ELTX

Elicio Therapeutics, Inc. (ELTX) reporting calendar

Elicio Therapeutics, Inc. files periodic reports with the SEC as ELTX on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
18 Jul 2026 – 8 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001601485-26-000042
10-K31 Dec 202512 Mar 202671 days0001601485-26-000027
10-Q30 Sep 202513 Nov 202544 days0001601485-25-000124
10-Q30 Jun 20257 Aug 202538 days0001601485-25-000111
10-Q31 Mar 202513 May 202543 days0001601485-25-000074
10-K31 Dec 202431 Mar 202590 days0001601485-25-000049
10-Q30 Sep 202413 Nov 202444 days0001601485-24-000075
10-Q30 Jun 202413 Aug 202444 days0001601485-24-000045
10-Q31 Mar 202415 May 202445 days0001601485-24-000033
10-K31 Dec 202329 Mar 202489 days0001601485-24-000023
10-Q30 Sep 202313 Nov 202344 days0001601485-23-000082
10-Q30 Jun 202314 Aug 202345 days0001601485-23-000052
10-Q31 Mar 202310 May 202340 days0001601485-23-000035
10-K31 Dec 202217 Mar 202376 days0001601485-23-000011
10-Q30 Sep 202214 Nov 202245 days0001601485-22-000070
10-Q30 Jun 202215 Aug 202246 days0001601485-22-000066
10-Q31 Mar 202216 May 202246 days0001601485-22-000037
10-K31 Dec 202130 Mar 202289 days0001601485-22-000022
10-Q30 Sep 202112 Nov 202143 days0001601485-21-000068
10-Q30 Jun 202112 Aug 202143 days0001601485-21-000047
10-Q31 Mar 202117 May 202147 days0001601485-21-000017
10-K31 Dec 202030 Mar 202189 days0001601485-21-000007

Source: SEC EDGAR company submissions for CIK 0001601485. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.